Strontium Ranelate
- OralStrontium RanelateProtos
Mechanism of Action
- Stimulates osteoblastic differentiation / activity, and inhibits osteoclastic differentiation / activity.
Clinical Use
Indications
- Severe post-menopausal osteoporosis or osteoporosis in males, that is refractory to other medications.
- Contraindications
- Past DVT / PE
- Blood pressure >160/90
- Immobilisation
- Severe renal impairment
- Adverse Effects
- Headache
- Nausea / vomiting / diarrhea
- Myocardial infarction
- DVT / PE